124 related articles for article (PubMed ID: 33006113)
1. TWIST1 upregulation affects E-cadherin expression in brain metastases.
Brlek P; Bukovac A; Kafka A; Pećina-Šlaus N
Clin Transl Oncol; 2021 Jun; 23(6):1085-1095. PubMed ID: 33006113
[TBL] [Abstract][Full Text] [Related]
2. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
[TBL] [Abstract][Full Text] [Related]
3. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.
Casas E; Kim J; Bendesky A; Ohno-Machado L; Wolfe CJ; Yang J
Cancer Res; 2011 Jan; 71(1):245-54. PubMed ID: 21199805
[TBL] [Abstract][Full Text] [Related]
4. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
5. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
[TBL] [Abstract][Full Text] [Related]
6. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?
Montserrat N; Gallardo A; Escuin D; Catasus L; Prat J; Gutiérrez-Avignó FJ; Peiró G; Barnadas A; Lerma E
Hum Pathol; 2011 Jan; 42(1):103-10. PubMed ID: 20970163
[TBL] [Abstract][Full Text] [Related]
7. A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases.
Wang G; Dong W; Shen H; Mu X; Li Z; Lin X; Liu Y; Du J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):1028-32. PubMed ID: 21376622
[TBL] [Abstract][Full Text] [Related]
8. TWIST1 promotes invasion through mesenchymal change in human glioblastoma.
Mikheeva SA; Mikheev AM; Petit A; Beyer R; Oxford RG; Khorasani L; Maxwell JP; Glackin CA; Wakimoto H; González-Herrero I; Sánchez-García I; Silber JR; Horner PJ; Rostomily RC
Mol Cancer; 2010 Jul; 9():194. PubMed ID: 20646316
[TBL] [Abstract][Full Text] [Related]
9. PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer.
Avasarala S; Van Scoyk M; Karuppusamy Rathinam MK; Zerayesus S; Zhao X; Zhang W; Pergande MR; Borgia JA; DeGregori J; Port JD; Winn RA; Bikkavilli RK
J Biol Chem; 2015 May; 290(21):13479-89. PubMed ID: 25847239
[TBL] [Abstract][Full Text] [Related]
10. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis.
Proestling K; Birner P; Gamperl S; Nirtl N; Marton E; Yerlikaya G; Wenzl R; Streubel B; Husslein H
Reprod Biol Endocrinol; 2015 Jul; 13():75. PubMed ID: 26198055
[TBL] [Abstract][Full Text] [Related]
11. Benzo(a)pyrene enhances the EMT-associated migration of lung adenocarcinoma A549 cells by upregulating Twist1.
Chen X; Peng H; Xiao J; Guan A; Xie B; He B; Chen Q
Oncol Rep; 2017 Oct; 38(4):2141-2147. PubMed ID: 28791412
[TBL] [Abstract][Full Text] [Related]
12. The role of TWIST1 in epithelial-mesenchymal transition and cancers.
Zhu QQ; Ma C; Wang Q; Song Y; Lv T
Tumour Biol; 2016 Jan; 37(1):185-97. PubMed ID: 26602382
[TBL] [Abstract][Full Text] [Related]
13. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
14. miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells.
Yeh TC; Huang TT; Yeh TS; Chen YR; Hsu KW; Yin PH; Lee HC; Tseng LM
PLoS One; 2016; 11(12):e0168171. PubMed ID: 27930738
[TBL] [Abstract][Full Text] [Related]
15. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
16. Twist1-induced dissemination preserves epithelial identity and requires E-cadherin.
Shamir ER; Pappalardo E; Jorgens DM; Coutinho K; Tsai WT; Aziz K; Auer M; Tran PT; Bader JS; Ewald AJ
J Cell Biol; 2014 Mar; 204(5):839-56. PubMed ID: 24590176
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
[TBL] [Abstract][Full Text] [Related]
18. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
Pei XH; Lv XQ; Li HX
Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
[TBL] [Abstract][Full Text] [Related]
20. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
